Johnson & Johnson COVID vaccine linked to loss of life in South Africa, health regulator reports

NEWYou can now pay attention to G3 Box News posts!

South Africa’s health regulator reported on Thursday a causal backlink between the loss of life of an personal and Johnson & Johnson’s (J&J) COVID-19 vaccine, the 1st time such a immediate link has been produced in the region.

The human being introduced with uncommon neurological condition Guillain-Barre Syndrome soon following getting offered J&J’s Janssen vaccine, soon after which the individual was set on a ventilator and later on died, senior scientists explained to a news conference.

“At the time of ailment no other lead to for the Guillain-Barre Syndrome (GBS) could be identified,” Professor Hannelie Meyer stated.

The person’s age and other personal facts were not disclosed for confidentiality causes.

Food and drug administration WARNS ON Likely JOHNSON & JOHNSON COVID-19 VACCINE Hyperlink TO Scarce Disorder

J&J reported in an emailed assertion that GBS was connected with the administration of many vaccines and other medications and can also be triggered by SARS-CoV-2, the virus that brings about COVID-19.

The J&J vaccine has been casually joined to a loss of life for the initial time in South Africa. Pictured: A health care worker administers a dose of the coronavirus vaccine in Johannesburg, South Africa, on Dec. 4, 2021.
(REUTERS/ Sumaya Hisham)

The organization explained it strongly supported increasing recognition of the signs and signs of uncommon situations to be certain they can be quickly discovered and efficiently dealt with.

Final July, U.S. authorities additional a warning to a factsheet for J&J’s vaccine declaring data recommended there was an improved possibility of GBS in the six weeks immediately after vaccination. At the time it mentioned 100 preliminary studies of GBS in vaccine recipients, which include 95 significant cases and one noted dying.

J&J reported at the time of the U.S. warning it was in conversations with regulators and the price of claimed cases of GBS in Janssen vaccine recipients exceeded the track record fee only a little.

“The benefit of vaccination even now significantly outweighs the risk,” Boitumelo Semete-Makokotlela, chief govt of the South African Health Goods Regulatory Authority (SAHPRA), told reporters.

“In our context we have administered about 9 million (doses) of the Janssen vaccine, and this is the very first causally linked circumstance of GBS.”

Europe’s medicines regulator past year extra GBS as a feasible aspect-influence of AstraZeneca’s COVID vaccine which, like J&J’s, uses viral vector know-how.

South Africa’s Health Minister Joe Phaahla explained to Thursday’s news convention that as of mid-July there experienced been just above 6,200 “adverse occasions” described to SAHPRA out of the more than 37 million COVID vaccine doses administered in the region, equal to .017%.


Semete-Makokotlela said the regulator had assessed all over 160 deaths since the COVID vaccination rollout began but experienced not seen a causal connection to vaccination until now.

South Africa has been making use of pictures from J&J and Pfizer in its COVID vaccination marketing campaign. The rollout bought off to a gradual begin due to challenges securing supplies and protracted negotiations with pharmaceutical providers, but more not long ago it has been slowed by hesitancy.

Close to 46% of its adult population of 40 million is now completely vaccinated.

Related Articles

Back to top button